WW International, Inc. (WW)
| Market Cap | 157.08M -53.7% |
| Revenue (ttm) | 665.49M -11.6% |
| Net Income | -101.28M |
| EPS | -10.14 |
| Shares Out | 10.00M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 325,487 |
| Open | 15.50 |
| Previous Close | 15.00 |
| Day's Range | 15.21 - 16.60 |
| 52-Week Range | 8.37 - 38.38 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 28.33 (+80.33%) |
| Earnings Date | Aug 5, 2026 |
About WW
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for WW stock is "Buy." The 12-month stock price target is $28.33, which is an increase of 80.33% from the latest price.
News
WW International Earnings Call Transcript: Q2 2026
Q2 saw revenue decline year-over-year but strong growth in higher-value Core+ and Clinical segments, driving a 10.2% ARPU increase. Debt was reduced by over 70% from pre-reorganization levels, and full-year guidance for revenue and adjusted EBITDA was reaffirmed.
WW International Earnings release: Q2 2026
WW International released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
WW International Shareholder letter: Q2 2026
WW International has published a letter to shareholders covering Q2 2026, which was released on August 5, 2026.
WW International Quarterly report: Q2 2026
WW International has published its Q2 2026 quarterly earnings report on August 5, 2026.
Weight Watchers Announces Second Quarter 2026 Results
Total End of Period Subscribers of 2.5 million; End of Period Clinical Subscribers of 197 thousand, up 55.7% year-over-year Core+ End of Period Subscribers of 541 thousand, up 13.9% year-over-year, re...
Weight Watchers Schedules Second Quarter 2026 Earnings Conference Call
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the second quarter 2026 ended June 30, 2026, after mar...
Walmart Super-Sizes Wellness Vision with Weight Watchers International Deal
Walmart’s ($WMT) Sam’s Club has teamed up with Weight Watchers International ($WW) to boost its wellness offering to Americans as they think more about their lifestyles and health. Benefits for…
Sam’s Club, WW announce wellness experience collaboration
Sam’s Club (WMT) and WW (WW) announced a new collaboration to create a wellness experience. The joint initiative between Sam’s Club and Weight Watchers combines guidance and nutrition counseling with…
Sam's Club® and Weight Watchers® Collaborate to Expand Access to Affordable, Holistic Wellness Experiences for Members
Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a new summer collaboration with ...
Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medi...
Weight Watchers to Support the American Heart Association's Healthy Living BEYOND Weight Study
Weight Watchers helps members achieve lasting weight loss through medication, personalized nutrition, and community support. As part of its collaboration with the American Heart Association, Weight Wa...
WW expands partnership with CheqUp in United Kingdom
WW (WW) International and CheqUp announced a significant expansion of their partnership, bringing together best-in-class behavioural and clinical support for people on a weight management journey in t...
Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK
The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss.
Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) and its affiliated medical groups (“Weight Watchers”), the global leader in science-backed weight management, is now acces...
WW International Proxy statement: Proxy filing
WW International filed a proxy statement on June 4, 2026, providing details for shareholder voting and corporate governance matters.
WW director buys $273.5K in common stock
In a regulatory filing, WW (WW) disclosed that its director Eugene Davis bought 20K shares of common stock on May 22-27 in a total transaction size of $273.5K. Shares are…
WW International Proxy statement: Proxy filing
WW International filed a proxy statement on May 15, 2026, providing details for shareholder voting and corporate governance matters.
Galloway Capital announces 8.42% stake in WW
Galloway Capital Partners announced that it has accumulated an ownership stake of approximately 8.42% in WW (WW) International. Galloway believes WW “is materially undervalued despite owning one of th...
WW up 5% to $10.13 after Galloway Capital announces stake
Galloway called WW (WW) shares “materially undervalued” in a press release on its stake.
Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price
NEW YORK--(BUSINESS WIRE)--Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW Internatio...
WW price target lowered to $20 from $21 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on WW (WW) to $20 from $21 and keeps an Equal Weight rating on the shares.
WW International Earnings Call Transcript: Q1 2026
Q1 2026 saw strong growth in clinical and Core+ segments, with clinical revenue up 32% and Core+ subscribers up 6% year-over-year. Revenue declined 10% overall, but ARPU rose 13% and gross margin remained near record highs. 2026 guidance for revenue and adjusted EBITDA was reaffirmed.
WW International Earnings release: Q1 2026
WW International released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
WW International Quarterly report: Q1 2026
WW International has published its Q1 2026 quarterly earnings report on May 7, 2026.